What is Lotemax used for?

Indications and Usage, quoted from the label by Bausch & Lomb Incorporated (NDA020583). Cross-references to other label sections are left out.

LOTEMAX is indicated for the treatment of steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation.

LOTEMAX is less effective than prednisolone acetate 1% in two 28-day controlled clinical studies in acute anterior uveitis, where 72% of patients treated with LOTEMAX experienced resolution of anterior chamber cells, compared to 87% of patients treated with prednisolone acetate 1%. The incidence of patients with clinically significant increases in IOP (≥10 mmHg) was 1% with LOTEMAX and 6% with prednisolone acetate 1%. LOTEMAX should not be used in patients who require a more potent corticosteroid for this indication.

LOTEMAX is also indicated for the treatment of post-operative inflammation following ocular surgery.

Source: DailyMed label, set id f37d74ac-5f9c-40a8-b43b-35148fc66bbe, version 12, effective April 17, 2023. NDC 24208-299, one of 1 listing for this product.

Indications and Usage, quoted from the label by Bausch & Lomb Incorporated (NDA200738). Cross-references to other label sections are left out.

LOTEMAX® (loteprednol etabonate ophthalmic ointment) 0.5% ointment is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.

Source: DailyMed label, set id 902a3c6b-2625-44ec-a077-926e012b3176, version 17, effective November 30, 2022. NDC 24208-443, one of 1 listing for this product.

Indications and Usage, quoted from the label by Bausch & Lomb Incorporated (NDA202872). Cross-references to other label sections are left out.

LOTEMAX ®(loteprednol etabonate ophthalmic gel) 0.5% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.

Source: DailyMed label, set id 9a666065-d467-42b8-8ecd-0ec1de9986d5, version 12, effective October 24, 2024. NDC 24208-503, one of 1 listing for this product.